US Patent Issued to SANOFI BIOTECHNOLOGY, REGENERON PHARAMACEUTICALS on April 21 for "Dosing regimens for use with PCSK9 inhibitors" (French, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,638, issued on April 21, was assigned to SANOFI BIOTECHNOLOGY (Gentilly, France) and REGENERON PHARAMACEUTICALS INC. (Tarrytown, N.Y.).

"Dosing regimens for use with PCSK9 inhibitors" was invented by Marie Baccara-Dinet (Paris), Laurence Bessac (Paris), Corinne Hanotin (Paris), Robert C. Pordy (Tarrytown, N.Y.), William J. Sasiela (Tarrytown, N.Y.) and Jacques Rey (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating a PCSK9-mediated disease or a PCSK9-mediated condition. Specifically, the invention relates to methods comprising the administration of a proprotein convertase subtilisin/kexin type 9...